Aclaris Therapeutics, Inc.
ACRS
Revenue
1.30M
▼-2.00M▼-60.75%
3 Months ChangeAssets
160.46M
▼-15.07M▼-8.59%
3 Months ChangeLiabilities
57.38M
▲1.94M▲3.51%
3 Months ChangeFree Cash Flow
-13.10M
▲7.85M▲37.47%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-02-26
Form 8-K
ID: 0001104659-26-020070
2026-01-12
Form 8-K
ID: 0001104659-26-002694
2026-01-06
Form 8-K
ID: 0001104659-26-001076
2025-11-06
Form 10-Q
ID: 0001104659-25-107788
2025-11-06
Form 8-K
ID: 0001104659-25-107353
2025-10-14
Form 8-K
ID: 0001104659-25-098991
2025-08-07
Form 10-Q
ID: 0001558370-25-010789
2025-08-07
Form 8-K
ID: 0001558370-25-010640
2025-07-29
Form 8-K
ID: 0001558370-25-009739
2025-06-30
Form 8-K
ID: 0001558370-25-008984